Navigation Links
America's Pharmaceutical Research Companies Respond to Hurricane Ike's Imminent Landfall
Date:9/12/2008

WASHINGTON, Sept. 12 /PRNewswire-USNewswire/ -- Responding to conditions created by Hurricane Ike in Texas and other Gulf Coast states, the Pharmaceutical Research and Manufacturers of America (PhRMA) has moved from "alert" to "engaged" status - the highest level of activation - as part of its effort to ensure needed medicines are available in areas affected by the storm. PhRMA is working closely with other members of the RxResponse network, http://www.rxresponse.org, to provide assistance to state, local and federal emergency managers to keep the pharmaceutical supply chain open throughout areas hit by Ike.

PhRMA, along with other RxResponse Coordinating Body members, are now convening regular conference calls to manage RxResponse's efforts to coordinate requests for needed medicines and supplies, as well as other critical information about the state of the pharmaceutical supply system throughout the affected region. PhRMA is specifically coordinating with its member companies and asking them to advise the RxResponse team of Ike-related impacts on company operations, as well as to monitor and report all requests for assistance.

"We will do all we can to assist emergency managers in Texas and everyone affected by Hurricane Ike," said PhRMA President & CEO Billy Tauzin. "We are working together with key players in the pharmaceutical supply system and with emergency managers on the ground to help ensure that medicines get to the patients, hospitals and emergency evacuation centers where they are needed most."

Created following Hurricane Katrina, RxResponse is a unique business-sector effort creating a single point of contact for emergency managers and public health leaders seeking help obtaining needed medicines after a natural or man-made disaster. The RxResponse is comprised of: the American Hospital Association, the American Red Cross, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Healthcare Distribution Management Association, the National Community Pharmacists' Association and PhRMA.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts
2. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
3. DNA Find in Oregon Is Oldest Yet Discovered in Americas
4. Olympus Corporation of the Americas Names Mark Gumz President & CEO
5. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
6. Cochlear Americas Announces 2008 Graeme Clark Scholarship Winners
7. Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
8. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
9. DSM Pharmaceutical Products Announces the Appointment of Thats Nice LLC as Agency of Record for Marketing
10. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
11. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th Annual ... Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised funds ... been wounded in battle and their families. Venture Construction Group is a 2016 Silver ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: